Latest stories on ONCY
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K34 · bearishgeneral
Oncolytics Biotech gains FDA Fast Track for pelareorep
TipRanks67 · bullishproduct/pr
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
Business Insider67 · bullishproduct/pr
Oncolytics Biotech advances REO 033 colorectal cancer program
TipRanks63 · neutralproduct/pr
Oncolytics Biotech Shares Rise on FDA Meeting Plan, Trial Progress in Colorectal Cancer
Morningstar63 · neutralproduct/pr
Oncolytics Biotech Advances toward Potential FDA Registration with Expanded Colorectal Cancer Trial
July 13, 2026
MarketChameleon73 · bullishproduct/pr
Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY)
InvestorsHub67 · bullishgeneral
Why Is Penny Stock Oncolytics Biotech (ONCY) Up Today?
TipRanks56 · neutralproduct/pr
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
ONCY Stock Surged Today – Here’s What Securing A Key Immunotherapy Patent Means For Oncolytics
Stocktwits News67 · bullishproduct/pr
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
TipRanks63 · neutralproduct/pr
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 | ONCY Stock News
StockTitan63 · neutralproduct/pr
Oncolytics Biotech Strengthens Leadership with New COO, Director
TipRanks63 · neutralgeneral
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
TipRanks63 · neutralproduct/pr
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
TipRanks63 · neutralproduct/pr